Patent US3938997A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3938997A Expired / Lapsed US ⏱️ 0.0 years remaining

Rapid access, air stable, regenerable iron chelate developer solutions

Assignee: 3M Co
•
Filing: 1975-03-28
•
Granted: 1976-02-17
•
Expires: 1995-03-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Rapid access, air stable, regenerable iron chelate developers comprising at least three developer materials, at least one selected from each of the groups comprising: 1. iron chelate developers 2. an ascorbic acid and 3. phenidone, glycin, cysteine hydrochloride, hydroxylamine sulfate, hydroquinone monosulfonate and 4-amino-N-ethyl-N-(β-methanesulfoneamidoethyl)-m-toludine.

Inventors

  • 👤 Richard S. Fisch
  • 👤 Norman Newman

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 17:37
CPC Classifications
G; G03; G03C; G03C5/00; G03C5/26; G03C5/29; G03C5/30

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 65 words
A superadditive non-fixing developer solution comprising at least three developer materials, the solution comprising an iron chelating developer, a second developer selected from the group consisting of ascorbic acid, sugartype derivatives of ascorbic acid, and stereoisomers and diastereoisomers of ascorbic acid and its sugar-type derivatives, and a third developer selected from the group consisting of 1-phenyl-3-pyrazolidone, glycin, cysteine hydrochloride, hydroxylamine sulfate, 4-amino-N-ethyl-N-(β-methanesulfoneamidoethyl)-m-toluidine, and hydroquinone monosulfonate.
Claim 2
Dependent Claim 65 words
A superadditive non-fixing developer solution comprising at least three developer materials, the solution comprising an iron chelating developer, a second developer selected from the group consisting of ascorbic acid, sugartype derivatives of ascorbic acid, and stereoisomers and diastereoisomers of ascorbic acid and its sugar-type derivatives, and a third developer selected from the group consisting of 1-phenyl-3-pyrazolidone, glycin, cysteine hydrochloride, hydroxylamine sulfate, 4-amino-N-ethyl-N-(β-methanesulfoneamidoethyl)-m-toluidine, and hydroquinone monosulfonate.
Claim 3
Dependent Claim 23 words
The developer solution of claim 1 wherein the organic portion of the iron chelating developer is selected from ethylenediaminetetraacetic acid and diethylenetriaminepentaacetic acid.
Claim 4
Dependent Claim 17 words
The developer solution of claim 1 wherein the second developer is selected from ascorbic and isoascorbic acid.
Claim 5
Dependent Claim 41 words
The developer solution of claim 1 wherein the iron chelating developer is selected from ferrous ethylenediaminetetraacetic acid and ferrous diethylenetriaminepentaacetic acid, the second developer is selected from ascorbic and isoascorbic acid, and the third developer is selected from 1-phenyl-3-pyrazolidone and 4-amino-N-ethyl-N-(β-methanesulfoneamidoethyl)-m-toluidine.
Claim 6
Dependent Claim 46 words
The developer of claim 1 wherein the concentration of the iron chelate developer is at least 0.05M, the concentration of the second developer is at least 0.05M and the concentration of the third developer is less than that of the second developer and at least 0.1mM.

References Cited (Backward Citations)

US2688549A Cited
US3567441A Cited
US3723126A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-02-16 1979-08-18 1980-02-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-02-16 1983-08-18 1984-02-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-02-16 1987-08-18 1988-02-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag